Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.

Yokohama K, Fukunishi S, Ii M, Nakamura K, Ohama H, Tsuchimoto Y, Asai A, Tsuda Y, Higuchi K.

Int J Mol Med. 2016 Nov;38(5):1499-1506. doi: 10.3892/ijmm.2016.2766. Epub 2016 Oct 3.

PMID:
28025996
2.

Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.

Orime K, Shirakawa J, Togashi Y, Tajima K, Inoue H, Nagashima Y, Terauchi Y.

Eur J Pharmacol. 2016 Feb 5;772:22-32. doi: 10.1016/j.ejphar.2015.12.043. Epub 2015 Dec 24.

PMID:
26724391
3.

Nonalcoholic fatty liver disease and hepatocellular carcinoma.

Zoller H, Tilg H.

Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23. Review.

PMID:
26907206
4.

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.

Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E.

World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.

5.

(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.

Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC.

Eur J Pharmacol. 2016 Oct 5;788:200-209. doi: 10.1016/j.ejphar.2016.06.040. Epub 2016 Jun 23.

PMID:
27343380
6.

Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.

Takegoshi K, Honda M, Okada H, Takabatake R, Matsuzawa-Nagata N, Campbell JS, Nishikawa M, Shimakami T, Shirasaki T, Sakai Y, Yamashita T, Takamura T, Tanaka T, Kaneko S.

Oncotarget. 2017 Mar 14;8(11):18191-18205. doi: 10.18632/oncotarget.15304.

7.

Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis.

Inoue-Yamauchi A, Itagaki H, Oda H.

Carcinogenesis. 2018 Jan 12;39(1):28-35. doi: 10.1093/carcin/bgx112.

8.

Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Wright JH, Johnson MM, Shimizu-Albergine M, Bauer RL, Hayes BJ, Surapisitchat J, Hudkins KL, Riehle KJ, Johnson SC, Yeh MM, Bammler TK, Beyer RP, Gilbertson DG, Alpers CE, Fausto N, Campbell JS.

Int J Cancer. 2014 Feb 15;134(4):778-88. doi: 10.1002/ijc.28421. Epub 2013 Sep 16.

9.
10.

Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.

Zhang L, Yang B, Yu B.

Biol Pharm Bull. 2015;38(7):1005-11. doi: 10.1248/bpb.b14-00892. Epub 2015 May 12.

11.

Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.

Li DJ, Liu J, Hua X, Fu H, Huang F, Fei YB, Lu WJ, Shen FM, Wang P.

Metabolism. 2018 Feb;79:52-63. doi: 10.1016/j.metabol.2017.11.002. Epub 2017 Nov 10.

PMID:
29129819
12.

Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.

Yoshimine Y, Uto H, Kumagai K, Mawatari S, Arima S, Ibusuki R, Mera K, Nosaki T, Kanmura S, Numata M, Tamai T, Moriuchi A, Tsubouchi H, Ido A.

Oncol Rep. 2015 Apr;33(4):1657-66. doi: 10.3892/or.2015.3745. Epub 2015 Jan 21.

PMID:
25607821
13.

MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.

Tessitore A, Cicciarelli G, Del Vecchio F, Gaggiano A, Verzella D, Fischietti M, Mastroiaco V, Vetuschi A, Sferra R, Barnabei R, Capece D, Zazzeroni F, Alesse E.

BMC Cancer. 2016 Jan 5;16:3. doi: 10.1186/s12885-015-2007-1.

14.

Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.

Okada Y, Yamaguchi K, Nakajima T, Nishikawa T, Jo M, Mitsumoto Y, Kimura H, Nishimura T, Tochiki N, Yasui K, Mitsuyoshi H, Minami M, Kagawa K, Okanoue T, Itoh Y.

Liver Int. 2013 Feb;33(2):301-11. doi: 10.1111/liv.12033.

PMID:
23295058
15.

Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.

Park EY, Choi H, Yoon JY, Lee IY, Seo Y, Moon HS, Hwang JH, Jun HS.

Mar Drugs. 2015 Nov 12;13(11):6866-83. doi: 10.3390/md13116866.

16.

Effect of hyperglycemia on hepatocellular carcinoma development in diabetes.

Niwa Y, Ishikawa K, Ishigami M, Honda T, Achiwa K, Izumoto T, Maekawa R, Hosokawa K, Iida A, Seino Y, Hamada Y, Goto H, Oiso Y, Arima H, Tsunekawa S.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):344-50. doi: 10.1016/j.bbrc.2015.05.066. Epub 2015 May 28.

17.

Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet.

Miura K, Ohnishi H, Morimoto N, Minami S, Ishioka M, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Isoda N, Yamamoto H.

Cancer Sci. 2019 Feb;110(2):771-783. doi: 10.1111/cas.13902. Epub 2019 Jan 9.

18.

Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.

Casagrande V, Mauriello A, Bischetti S, Mavilio M, Federici M, Menghini R.

Sci Rep. 2017 Jul 27;7(1):6747. doi: 10.1038/s41598-017-06439-x.

19.

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.

Hwang A, Shi C, Zhu E, Naaz F, Zhou P, Rasheed Z, Liu M, Jung LS, Duan B, Li J, Jiang K, Paka L, Gadhiya SV, Dana D, Ali Q, Yamin MA, Goldberg ID, Narayan P.

PLoS One. 2018 Jun 26;13(6):e0198937. doi: 10.1371/journal.pone.0198937. eCollection 2018.

20.

Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.

Ikawa-Yoshida A, Matsuo S, Kato A, Ohmori Y, Higashida A, Kaneko E, Matsumoto M.

Int J Exp Pathol. 2017 Aug;98(4):221-233. doi: 10.1111/iep.12240. Epub 2017 Sep 12.

Supplemental Content

Support Center